Sara Small, MD, PhD

Sara Small, MD, PhD

Assistant Professor

Treatment Focus

Acute Myeloid Leukemia

Research Program

Distinctions

  • Emblem-Hospitals-Procedures_Conditions_Leukemia-Lymphoma-Myeloma_2024-2025.

Clinical Locations

  • Fox Chase–Temple University Hospital Bone Marrow Transplant Program
    Temple University Hospital – Jeanes Campus
    Patient Care Center, Fifth Floor
    7600 Central Avenue
    Philadelphia, PA 19111

Educational Background

University of Pennsylvania School of Medicine (Medical Scientist Training Program), Philadelphia, PA (2009-2017),

  • M.D., Graduation: May 2017
  • Ph.D., Cellular and Molecular Biology (August 2015)

Columbia University, New York, NY (2003-2007) B.A., Religion

Selected Publications

Small S, Oh T, Platanias LC. Role of biomarkers in the management of acute myeloid leukemia. Int J Mol Sci. 2022: 23(23):14543.

Small S, Tang E, Ragland R, Ruzankina Y, Schoppy D, Glineburg M, Ustelenca Z, Powell D, Simpkins F, Johnson F, and Brown E. Induction of Interleukin-19 through JNK and cGAS-STING modulates DNA-damage-induced cytokine expression. Sci Signal. 2021 Dec. 

Small S, Numan Y, and Platanias LC. 2021. Innate immune mechanisms and immunotherapy in myeloid malignancies. Biomedicines. 2021 Nov;9(11):1631.

Small S, Altman JK, and Platanias LC. Interferon maintenance for prevention of relapse in favorable risk AML? Leuk Lymphoma. 2021 Dec;62(12):2818-2819. 

Small S and Ma S. Frontline treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): targeted therapy versus chemoimmunotherapy. Curr Hematol Malig Rep. 2021 Aug;16(4):325-335. 

Mina A, Small S, and Platanias LC. 2021. Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections. Leuk Lymphoma. 2021 Jun;62(6):1284-1286.

Small S, Barnea Slonim L, Williams C, and Karmali R. B cell lymphomas of the GI tract. Curr Gastroenterol Rep. 2021 May;23(7):9. 

Small S, Keerthivasan G, Huang Z, Gurbuxani S, and Crispino JD. Overexpression of Survivin Initiates Hematologic Malignancies in Vivo. Leukemia. 2010 Nov;24(11):1920–1926.

Keerthivasan G, Small S, Liu H, Wickrema A, and Crispino JD. Vesicle Trafficking Plays a Novel Role in Erythroblast Enucleation. Blood. 2010 Oct;116(17):3331–3340.

Wen Q, Leung C, Huang Z, Small S, Reddi AL, Licht JD, and Crispino JD. Survivin Is Not Required for the Endomitotic Cell Cycle of Megakaryocytes. Blood. 2009;114(1):153–156.

Baldwin BR, Li L, Tse K-F, Small S, Collector M, Whartenby KA, Sharkis SJ, Racke F, Huso D, and Small D. Transgenic Mice Expressing Tel-FLT3, a Constitutively Activated Form of FLT3, Develop Myeloproliferative Disease. Leukemia. 2007 Apr;21(4):764–771.
 

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...